
Consider the cannabis deregulation theme, where insider buying in stocks like Tilray (TLRY) preceded a significant rally. A potentially lower-risk strategy involves buying shares when insiders do just before an earnings report, as seen with Resideo Technologies (REZI). Keep the drone and counter-drone sector on your watchlist as a developing theme with potential government backing. For high-risk, high-reward opportunities, consider buying biotech stocks before a major catalyst like clinical trial results and selling immediately after the news is released. Always remember to take profits, as even winning trades with strong insider signals can reverse course.